Connor Clark & Lunn Investment Management Ltd. Buys Shares of 421,993 Oscar Health, Inc. (NYSE:OSCR)

Connor Clark & Lunn Investment Management Ltd. purchased a new position in Oscar Health, Inc. (NYSE:OSCR) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 421,993 shares of the company’s stock, valued at approximately $5,672,000. Connor Clark & Lunn Investment Management Ltd. owned 0.17% of Oscar Health as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the company. State Street Corp lifted its holdings in Oscar Health by 6.0% in the third quarter. State Street Corp now owns 5,132,802 shares of the company’s stock valued at $108,867,000 after buying an additional 291,335 shares during the period. Lingotto Investment Management LLP acquired a new position in shares of Oscar Health in the 4th quarter valued at about $2,543,000. GDS Wealth Management boosted its position in shares of Oscar Health by 1,545.3% during the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock valued at $4,648,000 after purchasing an additional 324,798 shares in the last quarter. Nordea Investment Management AB acquired a new stake in Oscar Health during the fourth quarter worth approximately $1,056,000. Finally, Janney Montgomery Scott LLC bought a new stake in Oscar Health in the third quarter worth approximately $988,000. 75.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

OSCR has been the subject of several recent analyst reports. Jefferies Financial Group assumed coverage on shares of Oscar Health in a research report on Tuesday, December 10th. They set an “underperform” rating and a $12.00 price objective for the company. Wells Fargo & Company downgraded shares of Oscar Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $20.00 to $16.00 in a research note on Thursday. Two analysts have rated the stock with a sell rating, three have given a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $20.19.

Oscar Health Trading Up 2.7 %

OSCR opened at $13.23 on Friday. The firm has a market capitalization of $3.31 billion, a PE ratio of -660.92 and a beta of 1.75. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. Oscar Health, Inc. has a fifty-two week low of $12.43 and a fifty-two week high of $23.79. The company’s 50-day moving average is $15.21 and its 200 day moving average is $16.38.

Oscar Health (NYSE:OSCR) last posted its earnings results on Tuesday, February 4th. The company reported ($0.62) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, research analysts predict that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.